Related Experiment Videos
Cancer pathology in the year 2000
C E Mountford1, S Doran, C L Lean
1Institute for Magnetic Resonance Research, University of Sydney, NSW, Australia.
Biophysical Chemistry
|February 20, 1998
Summary
Proton magnetic resonance spectroscopy (1H MRS) detects chemical markers in biopsies to diagnose cancer. This technique shows promise for improving cancer assessment and guiding biopsies.
Area of Science:
- Biomedical Engineering
- Medical Physics
- Oncology
Background:
- Histopathology, while advanced, still relies on subjective interpretation for cancer diagnosis.
- Existing diagnostic methods for cancer can be limited in precision and invasiveness.
Purpose of the Study:
- To explore the utility of proton magnetic resonance spectroscopy (1H MRS) in identifying chemical markers of cancer.
- To investigate the potential of 1H MRS and chemical shift imaging (CSI) for improved cancer assessment and image-guided biopsies.
Main Methods:
- Utilizing ex vivo 1H MRS to analyze chemical alterations in biopsies and fine needle aspirates.
- Employing 1H chemical shift imaging (CSI) to spatially map chemical changes within tissues.
- Correlating in vivo 1H MRS data with biopsy histology.
Main Results:
- 1H MRS can distinguish between invasive and pre-invasive cervical lesions.
- The technique differentiates benign follicular neoplasms from follicular carcinomas using minimal cell samples.
- CSI provides insights into the chemistry of neoplastic transformation.
Conclusions:
- 1H MRS offers a sensitive method for detecting neoplastic chemical changes.
- CSI is hypothesized to enhance image-guided biopsy techniques by year 2000.
- In vivo 1H MRS holds potential for accurate tumor size, location, and neoplastic potential determination.